• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

31.02 EUR

As of 00:00:00 ET on 12/19/2014.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +50.07% 3-Month: +18.94% 3-Year: +45.97% 52-Week Range: 20.67 - 31.02
1-Month: +6.71% 1-Year: +50.51% 5-Year: +36.31% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 31.02
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2014-12-19) 31.02
Assets (M) (on 2014-11-28) 27.20
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 11/28/2014
Name Position Value % of Total
Celgene Corp 29,000 2,655,696 9.764%
Gilead Sciences Inc 27,500 2,222,017 8.170%
Vertex Pharmaceuticals Inc 21,900 2,089,848 7.684%
Alexion Pharmaceuticals Inc 12,100 1,898,391 6.980%
Biogen Idec Inc 7,000 1,740,284 6.398%
Mylan Inc/PA 29,000 1,350,185 4.964%
Jazz Pharmaceuticals PLC 8,900 1,261,952 4.640%
Medivation Inc 13,500 1,245,696 4.580%
Regeneron Pharmaceuticals Inc 3,700 1,234,412 4.539%
BioMarin Pharmaceutical Inc 16,800 1,218,755 4.481%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil